N-Ethylhexedrone was patented through the German pharmaceutical organization Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[1]The cognitive effects of mephedrone is usually broken down into several elements which progressively intensify proportional to